Benitec Biopharma

(NASDAQ) BNTC

Current Price$11.44

Market Cap$394.73M

Since IPO (2014)-100%

5 Year-85%

1 Year-15%

1 Month-16%

Benitec Biopharma Financials at a Glance

Market Cap

$394.73M

Revenue (TTM)

$556.00K

Net Income (TTM)

$48.88M

EPS (TTM)

$-0.93

P/E Ratio

-12.37

Dividend

$0.00

Beta (Volatility)

0.86 (Low)

Dividend

$0.00

Beta (Volatility)

0.86 (Low)

Price

$11.44

Volume

103,035

Open

$11.37

Price

$11.44

Volume

103,035

Open

$11.37

Previous Close

$11.49

Daily Range

$11.00 - $11.81

52-Week Range

$9.85 - $17.15

Dividend

$0.00

Beta (Volatility)

0.86 (Low)

Price

$11.44

Volume

103,035

Open

$11.37

Previous Close

$11.49

Daily Range

$11.00 - $11.81

52-Week Range

$9.85 - $17.15

BNTC News

No articles available.

BNTC: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Benitec Biopharma

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Jerel A. Banks, MD, PhD

Website

www.benitec.com

Headquarters

Hayward, CA 94545, US

BNTC Financials

Key Financial Metrics (TTM)

Gross Margin

29%

Operating Margin

-97%

Net Income Margin

-88%

Return on Equity

-30%

Return on Capital

-29%

Return on Assets

-26%

Earnings Yield

-8.08%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$394.73M

Shares Outstanding

34.35M

Volume

103.03K

Avg. Volume

151.04K

Financials (TTM)

Gross Profit

$396.00K

Operating Income

$41.77M

EBITDA

$41.70M

Operating Cash Flow

$23.59M

Capital Expenditure

$18.00K

Free Cash Flow

$23.61M

Cash & ST Invst.

$97.74M

Total Debt

$849.00K

Benitec Biopharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$119.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$394.73M

N/A

Market Cap/Employee

$24.67M

N/A

Employees

N/A

Net Income

$11.94M

-27.6%

EBITDA

$13.46M

-33.5%

Quarterly Fundamentals

Name

Q3 2026YOY CHG

Net Cash

$183.88M

+79.2%

Accounts Receivable

$3.00K

+0.0%

Inventory

$0.00

N/A

Long Term Debt

$394.00K

-35.7%

Short Term Debt

$482.00K

+39.3%

Return on Assets

-26.14%

N/A

Return on Invested Capital

-29.36%

N/A

Free Cash Flow

$4.93M

-59.4%

Operating Cash Flow

$4.91M

-59.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PRTCPureTech Health plc

PRTCPureTech Health plc$17.39-3.17%

AUTLAutolus Therapeutics plc

AUTLAutolus Therapeutics plc$1.63+2.52%

OCGNOcugen, Inc.

OCGNOcugen, Inc.$1.39-4.79%

NGNENeurogene Inc.

NGNENeurogene Inc.$29.82-4.64%

XOMAXOMA Royalty Corp.

XOMAXOMA Royalty Corp.$41.75-0.60%

SLDBSolid Biosciences Inc.

SLDBSolid Biosciences Inc.$6.92-9.31%

IMABI-Mab

IMABI-Mab$2.88-0.69%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.95-0.04%

FFord Motor Company

FFord Motor Company$13.40-0.07%

POETPoet Technologies

POETPoet Technologies$15.97-0.22%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.06-0.10%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.34-0.05%

FIGFigma

FIGFigma$22.92+0.13%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.98+0.05%

Questions About BNTC

What is the current price of Benitec Biopharma?

Benitec Biopharma is trading at $11.49 per share.

What is the 52-week range for Benitec Biopharma?

Over the past 52 weeks, Benitec Biopharma has traded between $9.85 and $17.15.

How much debt does Benitec Biopharma have?

As of the most recent reporting period, Benitec Biopharma reported total debt of $876,000.

How much cash does Benitec Biopharma have on hand?

Benitec Biopharma reported $184.88M in cash and cash equivalents in its most recent financial results.

What is Benitec Biopharma’s dividend yield?

Benitec Biopharma does not currently have a dividend yield.

Benitec Biopharma

Benitec Biopharma Financials at a Glance

BNTC News

BNTC: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Benitec Biopharma

BNTC Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Benitec Biopharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BNTC

What is the current price of Benitec Biopharma?

What is the 52-week range for Benitec Biopharma?

How much debt does Benitec Biopharma have?

How much cash does Benitec Biopharma have on hand?

What is Benitec Biopharma’s dividend yield?

Premium Investing Services